Effects of c9,t11-conjugated linoleic acid on adhesion of human gastric carcinoma cell line SGC-7901

World J Gastroenterol. 2004 May 15;10(10):1392-6. doi: 10.3748/wjg.v10.i10.1392.

Abstract

Aim: To investigate the effect of c9,t11-conjugated linoleic acid (c9,t11-CLA) on the adhesion of human gastric carcinoma cell line (SGC-7901).

Methods: SGC-7901 cells were at first treated with different concentrations (25, 50, 100, 200 micromol/L) of c9,t11-CLA and 1 mL/L ethanol (as a negative control) for 24 h. Using adhesion assay and Western blot, we investigated the ability of SGC-7901 cells to adhere to intracellular matrix and examined the expression of E-cadherin (ECD), alpha-catenin, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in these cells.

Results: The attachment rate to laminin of SGC-7901 cells treated with different concentrations of c9,t11-CLA (0, 25, 50, 100, and 200 micromol/L) was 100.0+/-3.3, 95.7+/-4.0, 89.2+/-4.6, 87.9+/-6.1, and 65.9+/-5.8, respectively. The attachment rate to fibronectin was 100.0+/-4.7, 96.8+/-3.8, 94.5+/-4.1, 76.5+/-4.3, and 61.8+/-4.8, respectively. The attachment rate to Matrigel was 99.9+/-6.6, 91.4+/-6.8, 85.5+/-7.4, 79.3+/-5.6, and 69.6+/-5.1, respectively. Besides, c9,t11-CLA could increase the level of ECD and alpha-catenin, and decrease the level of ICAM-1 and VCAM-1 in SGC-7901 cells.

Conclusion: c9,t11-CLA can reduce the adhesion of human gastric carcinoma cells to laminin, fibronectin and Matrigel. c9,t11-CLA can increase the level of ECD and alpha-catenin, and decrease the level of ICAM-1 and VCAM-1 in human gastric carcinoma cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cadherins / metabolism
  • Cell Adhesion / drug effects*
  • Cell Line, Tumor
  • Collagen / metabolism
  • Cytoskeletal Proteins / metabolism
  • Drug Combinations
  • Fibronectins / metabolism
  • Humans
  • Intercellular Adhesion Molecule-1 / metabolism
  • Laminin / metabolism
  • Linoleic Acid / chemistry*
  • Linoleic Acid / pharmacology*
  • Linoleic Acid / therapeutic use
  • Proteoglycans / metabolism
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / metabolism*
  • Vascular Cell Adhesion Molecule-1 / metabolism
  • alpha Catenin

Substances

  • CTNNA1 protein, human
  • Cadherins
  • Cytoskeletal Proteins
  • Drug Combinations
  • Fibronectins
  • Laminin
  • Proteoglycans
  • Vascular Cell Adhesion Molecule-1
  • alpha Catenin
  • matrigel
  • Intercellular Adhesion Molecule-1
  • Collagen
  • Linoleic Acid